These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8510026)

  • 21. Signal transduction mediated by angiotensin II receptor subtypes expressed in rat renal mesangial cells.
    Madhun ZT; Ernsberger P; Ke FC; Zhou J; Hopfer U; Douglas JG
    Regul Pept; 1993 Mar; 44(2):149-57. PubMed ID: 8469770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unilateral ureteral obstruction increases glomerular soluble guanylyl cyclase activity.
    McDowell KA; Chevalier RL; Thornhill BA; Norling LL
    J Am Soc Nephrol; 1995 Nov; 6(5):1498-503. PubMed ID: 8589329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine attenuates the contractile response to angiotensin II in isolated rat glomeruli and cultured mesangial cells.
    Barnett R; Singhal PC; Scharschmidt LA; Schlondorff D
    Circ Res; 1986 Nov; 59(5):529-33. PubMed ID: 3467880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DuP 753 is a potent nonpeptide antagonist of angiotensin II receptors in isolated perfused rat kidney and cultured renal cells.
    Fontoura BM; Nussenzveig DR; Timmermans PB; Maack T
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):303S-308S. PubMed ID: 1854456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the angiotensin II receptor antagonist MK 954 on the angiotensin II-induced increase in free cytosolic Ca2+ and growth in vascular smooth muscle cells.
    Sachinidis A; Görg A; Ko Y; Wieczorek AJ; Düsing R; Vetter H
    J Hypertens Suppl; 1991 Dec; 9(6):S226-7. PubMed ID: 1818954
    [No Abstract]   [Full Text] [Related]  

  • 26. Interaction of nonpeptide angiotensin II receptor antagonists with the urate transporter in rat renal brush-border membranes.
    Edwards RM; Trizna W; Stack EJ; Weinstock J
    J Pharmacol Exp Ther; 1996 Jan; 276(1):125-9. PubMed ID: 8558420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of glomerular angiotensin II receptor subtypes.
    Gauquelin G; Garcia R
    Receptor; 1992; 2(3):207-12. PubMed ID: 1472951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonpeptide angiotensin II receptor antagonist: pharmacokinetics and pharmacodynamics in rats of EXP3174, an active metabolite of losartan.
    Wong PC; Christ DD; Wong YN; Lam GN
    Pharmacology; 1996 Jan; 52(1):25-9. PubMed ID: 8966199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histamine modulates contraction and cyclic nucleotides in cultured rat mesangial cells. Differential effects mediated by histamine H1 and H2 receptors.
    Sedor JR; Abboud HE
    J Clin Invest; 1985 May; 75(5):1679-89. PubMed ID: 2582001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II-induced calcium signalling in isolated glomeruli from fish kidney (Oncorhynchus mykiss) and effects of losartan.
    Cobb CS; Williamson R; Brown JA
    Gen Comp Endocrinol; 1999 Feb; 113(2):312-21. PubMed ID: 10082634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II.
    Gorbea-Oppliger VJ; Fink GD
    J Pharmacol Exp Ther; 1995 May; 273(2):611-6. PubMed ID: 7752062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of angiotensin II and antagonists on AT(1) receptor expression in mesangial cells.
    Chansel D; Vandermeersch S; Llorens-Cortes C; Ardaillou R
    Eur J Pharmacol; 1999 Nov; 384(2-3):223-30. PubMed ID: 10611445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
    Kabour A; Henegar JR; Devineni VR; Janicki JS
    Cardiovasc Res; 1995 Apr; 29(4):543-8. PubMed ID: 7796449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of captopril and the nonpeptide angiotensin II antagonists, SK&F 108566 and EXP3174, on renal function in dogs with a renal artery stenosis.
    Brooks DP; DePalma PD; Ruffolo RR
    J Pharmacol Exp Ther; 1992 Nov; 263(2):422-7. PubMed ID: 1432681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glomerular mesangial cell altered contractility in high glucose is Ca2+ independent.
    Hurst RD; Stevanovic ZS; Munk S; Derylo B; Zhou X; Meer J; Silverberg M; Whiteside CI
    Diabetes; 1995 Jul; 44(7):759-66. PubMed ID: 7789643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells.
    Bakris GL; Re RN
    Am J Physiol; 1993 Jun; 264(6 Pt 2):F937-42. PubMed ID: 8322895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II as a stimulator of Na(+)-dependent Ca2+ efflux from freshly isolated adult rat cardiomyocytes.
    Fukuta Y; Yoshizumi M; Kitagawa T; Hori T; Chikugo F; Kawahito T; Katoh I; Houchi H; Oka M
    Neurosci Lett; 1996 Aug; 213(2):95-8. PubMed ID: 8858617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II B-type receptor mediates phosphoinositide hydrolysis in mesangial cells.
    Pfeilschifter J
    Eur J Pharmacol; 1990 Aug; 184(1):201-2. PubMed ID: 2170150
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro effects of DuP 753, a nonpeptide angiotensin II receptor antagonist, on human platelets and rat vascular smooth muscle cells.
    Burnier M; Centeno G; Grouzmann E; Walker P; Waeber B; Brunner HR
    Am J Hypertens; 1991 May; 4(5 Pt 1):438-43. PubMed ID: 2069778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Image analyser as a tool for the study of in vitro glomerular vasoreactivity.
    Lakhdar B; Potier M; L'Azou B; Cambar J
    Cell Biol Toxicol; 1994 Dec; 10(5-6):291-5. PubMed ID: 7697487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.